Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line.

作者: Isa M. Hussaini , Christy Trotter , Yunge Zhao , Rana Abdel-Fattah , Samson Amos

DOI: 10.2353/AJPATH.2007.060736

关键词:

摘要: The complete resection of pituitary adenomas (PAs) is unlikely when there an extensive local dural invasion and given that the molecular mechanisms remain primarily unknown. DNA microarray analysis was performed to identify differentially expressed genes between nonfunctioning invasive noninvasive PAs. Gene clustering revealed a robust eightfold increase in matrix metalloproteinase (MMP)-9 expression surgically resected human PAs (nonfunctioning) HP75 tumor-derived cell line treated with phorbol-12-myristate-13-acetate; these results were confirmed by real-time polymerase chain reaction, gelatin zymography, reverse transcriptase-polymerase Western blot, immunohistochemistry, Northern blot analyses. activation protein kinase C (PKC) increased both MMP-9 activity expression, which blocked some PKC inhibitors (Go6976, bisindolylmaleimide, Rottlerin), PKC-α, PKC-δ small interfering (si)RNAs but not hispidin (PKC-β inhibitor). In transmembrane assay, phorbol-12-myristate-13-acetate (100 nmol/L) number invaded cells, process attenuated inhibitors, antibody, PKC-α siRNA, or siRNA. These demonstrate may provide putative therapeutic targets for control PA invasion.

参考文章(52)
Sajal Chakraborti, Malay Mandal, Sudip Das, Amritlal Mandal, Tapati Chakraborti, Regulation of matrix metalloproteinases: an overview. Molecular and Cellular Biochemistry. ,vol. 253, pp. 269- 285 ,(2003) , 10.1023/A:1026028303196
Yasutomi Nishizuka, Protein kinase C and lipid signaling for sustained cellular responses. The FASEB Journal. ,vol. 9, pp. 484- 496 ,(1995) , 10.1096/FASEBJ.9.7.7737456
A Nykjaer, C.M. Petersen, B Møller, P.H. Jensen, S.K. Moestrup, T.L. Holtet, M Etzerodt, H.C. Thøgersen, M Munch, P.A. Andreasen, Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. Journal of Biological Chemistry. ,vol. 267, pp. 14543- 14546 ,(1992) , 10.1016/S0021-9258(18)42072-8
Nelson M. Oyesiku, Victoria L. Stevens, Branch Craige, Eric B. O'Neill, Chheng Orn Evans, Daniel J. Brat, Prasad Reddy, Differential expression of folate receptor in pituitary adenomas. Cancer Research. ,vol. 63, pp. 4218- 4224 ,(2003)
Jussi Koivunen, Vesa Aaltonen, Sanna Koskela, Petri Lehenkari, Matti Laato, Juha Peltonen, Protein Kinase C α/β Inhibitor Go6976 Promotes Formation of Cell Junctions and Inhibits Invasion of Urinary Bladder Carcinoma Cells Cancer Research. ,vol. 64, pp. 5693- 5701 ,(2004) , 10.1158/0008-5472.CAN-03-3511
H. E. Turner, Zs. Nagy, M. M. Esiri, A. L. Harris, J. A. H. Wass, Role of Matrix Metalloproteinase 9 in Pituitary Tumor Behavior The Journal of Clinical Endocrinology and Metabolism. ,vol. 85, pp. 2931- 2935 ,(2000) , 10.1210/JCEM.85.8.6754
U Schiemann, R Assert, D Moskopp, R Gellner, K Hengst, F Gullotta, W Domschke, A Pfeiffer, Analysis of a protein kinase C-α mutation in human pituitary tumours Journal of Endocrinology. ,vol. 153, pp. 131- 137 ,(1997) , 10.1677/JOE.0.1530131
Shunichi Yokoyama, Hirofumi Hirano, Koichi Moroki, Masamichi Goto, Shinichi Imamura, Jun-ichi Kuratsu, Are Nonfunctioning Pituitary Adenomas Extending into the Cavernous Sinus Aggressive and/or Invasive? Neurosurgery. ,vol. 49, pp. 857- 863 ,(2001) , 10.1097/00006123-200110000-00014
Björn P. Meij, Maria-Beatriz S. Lopes, Dilantha B. Ellegala, Tord D. Alden, Edward R. Laws, The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. Journal of Neurosurgery. ,vol. 96, pp. 195- 208 ,(2002) , 10.3171/JNS.2002.96.2.0195